CoChat

Delays in Initiation of Acyclovir Therapy in Herpes Simplex Encephalitis

Open access
Hughes, Peter S., Jackson, Alan C. · 2012 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Background: Diagnosis of herpes simplex encephalitis (HSE) is based on clinical findings, MRI, and detection of herpes simplex virus (HSV) DNA in cerebrospinal fluid (CSF) using polymerase chain reaction amplification. Delays in starting treatment are associated with poorer clinical outcomes. We assessed the timing of initiation of acyclovir therapy in HSE. Methods: Inpatient databases from seven hospitals in Winnipeg, Manitoba were used to identify individuals diagnosed with encephalitis and HSE from 2004 to 2009. The time taken to initiate therapy with acyclovir and the reasons for delays were determined. Results: Seventy-seven patients were identified; 69 (90%) received acyclovir; in the others a non-HSV infection was strongly suspected. Thirteen patients were subsequently confirmed to have HSE. Acyclovir was initiated a median of 21 hours (3-407) after presentation in encephalitis cases, and a median of 11 hours (3-118) in HSE. The most common reason for delay was a failure to consider HSE in the differential diagnosis, despite suggestive clinical features. Where therapy was delayed in HSE patients, the decision to begin acyclovir was prompted by transfer of the patient to a different service (55%), recommendations by consultants (18%), imaging results (18%), and CSF pleocytosis (9%). Conclusions: Delays in initiating acyclovir for HSE are common, and are most often due to a failure to consider HSE in a timely fashion on presentation. In order to improve patient outcomes, physicians should be more vigilant for HSE, and begin acyclovir therapy expeditiously on the basis of clinical suspicion rather than waiting for confirmatory tests.

Overview

Integrity signals

Registry

Crossref · 10.1017/s0317167100015390

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 17 references

Cited by

See all 44

Metadata

Authors
Hughes, P. S., & Jackson, A. C.
Affiliations
University of Manitoba (CA)
Corresponding author
Jackson, Alan C.
Venue
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
Published
2012-09
Volume
39
Issue
5
Pages
644-648
ISSN
  • 0317-1671 (ISSN-L)
  • 2057-0155
OpenAlex
W2044602866
Cited by
44
References
17
Citations by year
2026: 2 · 2025: 6 · 2024: 2 · 2023: 3 · 2022: 3 · 2021: 2 · 2019: 4 · 2018: 4 · 2017: 3 · 2016: 2 · 2015: 7 · 2014: 3 · 2013: 1 · 2012: 1
FWCI
2.86
Type
journal article
Language
en
Open access
Locations
  • Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
  • Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
  • Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
Keywords
herpes simplex encephalitis, acyclovir, treatment delay, antiviral therapy initiation, differential diagnosis, cerebrospinal fluid pleocytosis, clinical suspicion, herpes simplex virus, encephalitis
MeSH terms
Acyclovir, Adolescent, Adult, Aged, Aged, 80 and over, Antiviral Agents, Diagnosis, Differential, DNA, Viral, Female, Herpes Simplex, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Retrospective Studies, Time Factors, Encephalitis, Herpes Simplex, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Delays in Initiation of Acyclovir Therapy in Herpes Simplex Encephalitis. https://app.cochat.ai/papers/10.1017/s0317167100015390
The paper
Hughes, P. S., & Jackson, A. C. (2012). Delays in Initiation of Acyclovir Therapy in Herpes Simplex Encephalitis. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. https://doi.org/10.1017/s0317167100015390

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.